TLDR Strategy Inc’s $1.44B reserve will cover at least 21 months of dividend payments Bitcoin fell to under $85K, leading Strategy Inc stock to drop 7.9% The reserve was funded through the sale of class A common stock Strategy Inc holds 650,000 BTC, about 3.1% of the total supply Strategy Inc announced on December 1, [...] The post Strategy Builds $1.44B Reserve to Avoid Bitcoin Liquidation Risk appeared first on CoinCentral.TLDR Strategy Inc’s $1.44B reserve will cover at least 21 months of dividend payments Bitcoin fell to under $85K, leading Strategy Inc stock to drop 7.9% The reserve was funded through the sale of class A common stock Strategy Inc holds 650,000 BTC, about 3.1% of the total supply Strategy Inc announced on December 1, [...] The post Strategy Builds $1.44B Reserve to Avoid Bitcoin Liquidation Risk appeared first on CoinCentral.

Strategy Builds $1.44B Reserve to Avoid Bitcoin Liquidation Risk

TLDR

  • Strategy Inc’s $1.44B reserve will cover at least 21 months of dividend payments
  • Bitcoin fell to under $85K, leading Strategy Inc stock to drop 7.9%

  • The reserve was funded through the sale of class A common stock

  • Strategy Inc holds 650,000 BTC, about 3.1% of the total supply


Strategy Inc announced on December 1, that it has established a US dollar reserve totaling $1.44 billion. The reserve was funded by selling shares of its class A common stock. The company stated the reserve will be used to support upcoming dividend and interest payments.

According to the company, the reserve covers 21 months of dividend payments and may eventually support up to 24 months. “Establishing a USD Reserve to complement our BTC Reserve marks the next step in our evolution,” said Michael Saylor, Executive Chairman of Strategy Inc. The firm plans to grow the reserve over time depending on market needs.

Despite this move, the company’s shares fell as much as 7.9% on Monday, marking the largest single-day drop in over a year. Investors expressed concern that the reserve might not be enough to prevent the company from selling Bitcoin if prices continue to fall.

Bitcoin Price Slide Raises Concerns About Future Sales

Bitcoin dropped by as much as 7% on Monday to below $85,000. The falling price raised fears that Strategy Inc could be forced to liquidate some of its holdings. The company currently owns 650,000 Bitcoin, which represents about 3.1% of the total supply.

The firm’s mNAV, a ratio comparing enterprise value to Bitcoin holdings, dropped to 1.14. If it falls below 1.0, the company may need to sell Bitcoin to cover payments. CEO Phong Le said on a podcast,

Strategy purchased 130 Bitcoin for about $11.7 million this week, funded again through share issuance. However, this consistent sale of equity to buy Bitcoin has created concern about shareholder dilution.

Earnings Guidance Adjusted Due to Market Volatility

The company also updated its full-year 2025 financial guidance. Previously, it had projected results based on a year-end Bitcoin price of $150,000. That assumption has now been revised to a range of $85,000 to $110,000 due to current market trends.

Based on that new range, Strategy expects its operating income to be between a loss of $7.0 billion and a profit of $9.5 billion. Net income could range from a $5.5 billion loss to a $6.3 billion gain. Diluted earnings per share are estimated between a $17 loss and a $19 gain.

These projections assume that the company continues raising capital and acquiring more Bitcoin. Strategy has adopted fair value accounting for its crypto assets, which causes income to fluctuate with the Bitcoin price.

Business Model Faces Pressure as Crypto Markets Cool

Strategy Inc’s shift from software development to Bitcoin accumulation has made it heavily reliant on cryptocurrency performance. With Bitcoin’s volatility, the firm’s business model is under increased scrutiny.

The company’s software business does not produce enough cash to fund dividends or interest payments. As Bitcoin generates no income, the company has relied on capital markets to fund its growth. This model, once popular, now faces doubts as markets become less receptive to high-risk strategies.

Index providers may soon drop Strategy from major indexes, according to JPMorgan analysts. This could lead to large outflows from passive funds, adding more pressure to the stock.

The firm said its Bitcoin KPI targets for 2025 now reflect expected yield between 22.0% and 26.0%, and a dollar gain of between $8.4 billion and $12.8 billion. These goals depend on further stock issuance and Bitcoin purchases throughout the year.

The post Strategy Builds $1.44B Reserve to Avoid Bitcoin Liquidation Risk appeared first on CoinCentral.

Market Opportunity
WorldAssets Logo
WorldAssets Price(INC)
$0.8988
$0.8988$0.8988
+1.58%
USD
WorldAssets (INC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23